drugset / Trial / NCT03353025

Study on Therapy of Non-invasive Prolactinoma

NCT03353025

RandomizedParallel-groupOpen-labelTreatment

Summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Timeline

Start
2016-01-01
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromocriptine Small molecule